<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Biotechnology News &#187; said-the-medicine</title>
	<atom:link href="http://www.biolexis.com/tag/said-the-medicine/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.biolexis.com</link>
	<description>Biotech news, biotechnology new and biotechnology articles.</description>
	<lastBuildDate>Sat, 31 Jul 2010 12:25:44 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>(AFX UK Focus) 2010-02-08 14:35 UPDATE 1-US FDA staff questions Cell Therapeutics drug data (Interactive Investor)</title>
		<link>http://www.biolexis.com/biotechnology-news/afx-uk-focus-2010-02-08-1435-update-1-us-fda-staff-questions-cell-therapeutics-drug-data-interactive-investor/</link>
		<comments>http://www.biolexis.com/biotechnology-news/afx-uk-focus-2010-02-08-1435-update-1-us-fda-staff-questions-cell-therapeutics-drug-data-interactive-investor/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 14:57:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology News]]></category>
		<category><![CDATA[brand]]></category>
		<category><![CDATA[data-from]]></category>
		<category><![CDATA[drug-reviewers]]></category>
		<category><![CDATA[food-security]]></category>
		<category><![CDATA[giving-the-usda]]></category>
		<category><![CDATA[leadership-on-food]]></category>
		<category><![CDATA[monday]]></category>
		<category><![CDATA[released-on-monday]]></category>
		<category><![CDATA[said-the]]></category>
		<category><![CDATA[said-the-medicine]]></category>
		<category><![CDATA[sell-pixantrone]]></category>
		<category><![CDATA[therapeutics]]></category>
		<category><![CDATA[under-the]]></category>
		<category><![CDATA[usda]]></category>

		<guid isPermaLink="false">http://www.biolexis.com/biotechnology-news/afx-uk-focus-2010-02-08-1435-update-1-us-fda-staff-questions-cell-therapeutics-drug-data-interactive-investor/</guid>
		<description><![CDATA[WASHINGTON, Feb 8 (Reuters) - U.S. drug reviewers questioned effectiveness data from Cell Therapeutics Inc for an experimental lymphoma drug and said the medicine carried substantial side effects, according to documents released on Monday. The Seattle-based biotechnology company is seeking approval to sell pixantrone under the brand name Pixuvri for treating non-Hodgkin's lymphoma that has ...]]></description>
			<content:encoded><![CDATA[<p>WASHINGTON, Feb 8 (Reuters) &#8211; U.S. drug reviewers questioned effectiveness data from Cell Therapeutics Inc for an experimental lymphoma drug and said the medicine carried substantial side effects, according to documents released on Monday. The Seattle-based biotechnology company is seeking approval to sell pixantrone under the brand name Pixuvri for treating non-Hodgkin&#8217;s lymphoma that has &#8230;</p>
<p>Here is the original:<br />
<a target="_blank" href="http://us.rd.yahoo.com/dailynews/rss/search/biotechnology/SIG=12s0dp9d5/*http://www.iii.co.uk/news/?type=afxnews&amp;articleid=7741716&amp;subject=general&amp;action=article" title="(AFX UK Focus) 2010-02-08 14:35 UPDATE 1-US FDA staff questions Cell Therapeutics drug data (Interactive Investor)">(AFX UK Focus) 2010-02-08 14:35 UPDATE 1-US FDA staff questions Cell Therapeutics drug data (Interactive Investor)</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.biolexis.com/biotechnology-news/afx-uk-focus-2010-02-08-1435-update-1-us-fda-staff-questions-cell-therapeutics-drug-data-interactive-investor/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
